This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Fibroblast growth factor receptor
From Proteopedia
(Difference between revisions)
| Line 14: | Line 14: | ||
<scene name='54/544712/Cv/2'>Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 with 2 molecules of fibroblast growth factor 1</scene> (PDB code [[1evt]]). | <scene name='54/544712/Cv/2'>Human fibroblast growth factor receptor 1 ligand-binding domain modules D2 and D3 with 2 molecules of fibroblast growth factor 1</scene> (PDB code [[1evt]]). | ||
| + | |||
| + | ==3D structures of fibroblast growth factor receptor== | ||
| + | [[Fibroblast growth factor receptor 3D receptor]] | ||
| + | |||
</StructureSection> | </StructureSection> | ||
==3D structures of fibroblast growth factor receptor== | ==3D structures of fibroblast growth factor receptor== | ||
| Line 24: | Line 28: | ||
*''FGFR1 tyrosine kinase domain residues 458-765'' | *''FGFR1 tyrosine kinase domain residues 458-765'' | ||
| + | **[[4uwy]], [[6mzq]] – hFGFR1 TKD - human<br /> | ||
**[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | **[[1fgk]], [[3kxx]], [[3ky2]], [[4rwi]], [[5flf]] – hFGFR1 TKD (mutant) - human <br /> | ||
| - | + | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[5o4a], [[6mzw]], [[6c1o]] – hFGFR1 TKD + inhibitor <br /> | |
| - | **[[4wun]], [[5am6]], [[5ew8]], [[5o49]], [[ | + | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]], [[6p68]], [[6p69]], [[6c18]], [[6c19]], [[6c1b]], [[6c1c]], [[5z0s]] – hFGFR1 TKD (mutant) + inhibitor <br /> |
| - | **[[1agw]], [[1fgi]], [[2fgi]], [[3c4f]], [[3js2]], [[3rhx]], [[4f63]], [[4f64]], [[4f65]], [[3tt0]], [[4nk9]], [[4nka]], [[4nks]], [[5b7v]], [[5am7]], [[4rwj]], [[4rwk]], [[4rwl]], [[4uwb]], [[4uwc]], [[4zsa]], [[5uq0]], [[5vnd]], [[5ur1]] | + | **[[5zv2]] – hFGFR1 TKD (mutant) + anti-cancer drug<br /> |
**[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | **[[3krj]] – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor <br /> | ||
**[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | **[[1xr0]] – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR<br /> | ||
| Line 98: | Line 103: | ||
**[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | **[[4qqj]], [[4qqt]] – hFGFR4 TKD (mutant) <br /> | ||
**[[5jkg]], [[5nwz]], [[5nud]] – hFGFR4 TKD + inhibitor<br /> | **[[5jkg]], [[5nwz]], [[5nud]] – hFGFR4 TKD + inhibitor<br /> | ||
| + | **[[6jpj]], [[5xff]], [[5xfj]] – hFGFR4 TKD (mutant) + inhibitor<br /> | ||
**[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | **[[4qrc]], [[4r6v]], [[4qqc]], [[4qq5]], [[4uxq]], [[4xcu]] – hFGFR4 TKD (mutant) + irreversible inhibitor<br /> | ||
Revision as of 07:54, 1 July 2019
| |||||||||||
3D structures of fibroblast growth factor receptor
Updated on 01-July-2019 {{#tree:id=OrganizedByTopic|openlevels=0|
- FGFR1
- FGFR1 tyrosine kinase domain residues 458-765
- 4uwy, 6mzq – hFGFR1 TKD - human
- 1fgk, 3kxx, 3ky2, 4rwi, 5flf – hFGFR1 TKD (mutant) - human
- 4wun, 5am6, 5ew8, 5o49, [[5o4a], 6mzw, 6c1o – hFGFR1 TKD + inhibitor
- 1agw, 1fgi, 2fgi, 3c4f, 3js2, 3rhx, 4f63, 4f64, 4f65, 3tt0, 4nk9, 4nka, 4nks, 5b7v, 5am7, 4rwj, 4rwk, 4rwl, 4uwb, 4uwc, 4zsa, 5uq0, 5vnd, 5ur1, 6p68, 6p69, 6c18, 6c19, 6c1b, 6c1c, 5z0s – hFGFR1 TKD (mutant) + inhibitor
- 5zv2 – hFGFR1 TKD (mutant) + anti-cancer drug
- 3krj – hFGFR1 TKD residues 538-678, 753-922 (mutant) + inhibitor
- 1xr0 – hFGFR1 residues 409-430 + FGFR signaling adaptor N terminal - NMR
- 3gqi – hFGFR1 TKD (mutant) with PTR + ACP
- 3gql – hFGFR1 TKD (mutant) + substrate
- 4uwy, 6mzq – hFGFR1 TKD - human
- FGFR1 ligand-binding domain D1 residues 35-208
- FGFR1 D1 complex with FGF
- 5w59 – hFGFR1 LBD D1 + FGF9
- 5w59 – hFGFR1 LBD D1 + FGF9
- FGFR1 D2,D3 residues 142-365 complex with FGF
- FGFR2
- FGFR2 tyrosine kinase domain
- 1gjo, 1oec, 2psq – hFGFR2 TKD
- 2pvy, 2pwl, 2py3, 2pz5, 2pzp, 2pzr, 2q0b, 4j95, 4j96, 4j97, 4j98, 4j99, 5ugx, 5uhn, 5ui0 – hFGFR2 TKD (mutant) + ACP
- 5ugl – hFGFR2 TKD (mutant) + ANP
- 3b2t – hFGFR2 TKD (mutant) + adenosine derivative
- 2pvf – hFGFR2 TKD with PTR + ACP + substrate peptide
- 3cly – hFGFR2 TKD (mutant) with PTR + ACP
- 5eg3 – hFGFR2 TKD (mutant) with PTR + ACP + phospholipase C γ
- 3ri1 – hFGFR2 TKD + inhibitor
- 1gjo, 1oec, 2psq – hFGFR2 TKD
- FGFR2 ligand-binding domain
- FGFR2 complex with FGF
- 1e0o – hFGFR2 (mutant) LBD D2,D3 + hFGF1 (mutant) + HS
- 3oj2, 3ojm – hFGFR2 (mutant) LBD D2,D3 + hFGF1
- 1djs – hFGFR2 LBD D2,D3 (mutant) + hFGF1
- 1ev2, 1ii4, 1iil – hFGFR2 LBD D2,D3 + hFGF2 (mutant)
- 4j23 – hFGFR2 LBD D2,D3 (mutant) + hFGF2 (mutant) + inhibitor
- 3cu1 – hFGFR2 LBD D2 + hFGF1
- 2fdb – hFGFR2 LBD D2,D3 + hFGF8b
- 1nun – hFGFR2 LBD D2,D3 + hFGF10
- 1e0o – hFGFR2 (mutant) LBD D2,D3 + hFGF1 (mutant) + HS
- FGFR3
- FGFR3 complex with FGF
- 1ry7 – hFGFR3 LBD + hFGF1
- 1ry7 – hFGFR3 LBD + hFGF1
- FGFR4
- FGFR4 tyrosine kinase domain
}}
References
- ↑ Coutts JC, Gallagher JT. Receptors for fibroblast growth factors. Immunol Cell Biol. 1995 Dec;73(6):584-9. PMID:8713482 doi:http://dx.doi.org/10.1038/icb.1995.92
- ↑ Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, Kaitila I, Loughlin J, Munnich A, Sykes B, Bonaventure J, Francomano CA. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998 Sep;63(3):711-6. PMID:9718331 doi:http://dx.doi.org/10.1086/302000
- ↑ Intini D, Baldini L, Fabris S, Lombardi L, Ciceri G, Maiolo AT, Neri A. Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14). Br J Haematol. 2001 Aug;114(2):362-4. PMID:11529856
- ↑ Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet. 1995 Dec;11(4):462-4. PMID:7493034 doi:http://dx.doi.org/10.1038/ng1295-462
